1-4 of 4
Otto J Visser, MD
Close
Sort by
Journal Articles

Subsequent Hematopoietic Stem Cell Transplantation in Belinostat-Treated Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (R/R PTCL)

Andrei R. Shustov, MD, Haifa Kathrin Al-Ali, MD, Gerald Wulf, MD, Pamela Hsu, Mi Rim Choi, Lee F Allen, Otto J Visser, MD, Pierre Zachee, MD PhD, Steven M. Horwitz, MD
Journal: Blood
Blood (2014) 124 (21): 5438.
https://doi.org/10.1182/blood.V124.21.5438.5438
Published: 2014
Journal Articles

Bortezomib Restores Defective Apoptosis by Upregulation of Noxa in Enteropathy-Associated T-Cell Lymphoma

Laura R de Baaij, MD, Marijn Radersma, MD, Jolanda MW van de Water, MD, Kim BJ Groot, Nathalie J Hijmering, Laura M Moesbergen, Otto J Visser, MD, Joost J Oudejans, MD, PhD, Chris JJ Mulder, MD, PhD, Chris JLM Meijer, MD, PhD, Saskia AGM Cillessen, PhD
Journal: Blood
Blood (2011) 118 (21): 2722.
https://doi.org/10.1182/blood.V118.21.2722.2722
Published: 2011
Journal Articles

90 yttrium Ibritumomab Tiuxetan-BEAM Followed by Autologous Stem Cell Transplantation Significantly Improves Overall Survival After Rituximab Containing Induction Therapy in Patients with High-Risk Aggressive B Cell Non-Hodgkin's Lymphoma

Marielle Wondergem, MD, Madelon de Rooij, MD, Josee Zijlstra, Otto J Visser, MD, Gert Ossenkoppele, MD, PhD, Peter C. Huijgens, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3078.
https://doi.org/10.1182/blood.V118.21.3078.3078
Published: 2011
Journal Articles

Enteropathy-Associated T-Cell Lymphoma: a Clinical Prognostic Model to Identify High Risk Patients

Laura R de Baaij, MD, Jolanda MW van de Water, MD, Wieke HM Verbeek, MD, PhD, Otto J Visser, MD, Dirk J Kuik, Msc, Joost J Oudejans, MD, PhD, Chris JLM Meijer, MD, PhD, Chris JJ Mulder, MD, PhD, Saskia AGM Cillessen, PhD
Journal: Blood
Blood (2010) 116 (21): 3092.
https://doi.org/10.1182/blood.V116.21.3092.3092
Published: 2010